Induction of cell-mediated responses against malarial erythrocytic stage through chemically pre-treated Burkitt lymphoma tumour cells.
D000818:Animals; D002051:Burkitt Lymphoma / Q000276:immunology*; D002417:Cattle; D002460:Cell Line; D006801:Humans; D007111:Immunity, Cellular / Q000187:drug effects*; D008154:Lucanthone / Q000031:analogs & derivatives* / Q000494:pharmacology; D008288:Malaria / Q000276:immunology*; D051379:Mice; D008805:Mice, Inbred A; D010962:Plasmodium berghei / Q000276:immunology; D013892:Thioxanthenes / Q000494:pharmacology*; D044004:Xanthones
D013892:Thioxanthenes; D044004:Xanthones; C027484:4-(beta-diethylaminoethylamino)-1,2-cyclohexenothiaxanthone; C027483:2-(beta-diethylaminoethylamino)-3,4-cyclohexenothia-xanthone; C027485:1-(beta-diethylaminoethylamino)-3,4-cyclohexenothiaxanthone; D008154:Lucanthone